Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 2 diabetes mellitus exacerbates vaginal group B <i>Streptococcus</i> colonization via impaired mucosal cytokine response.

mSphere·2026
Same author

Mucin-derived sugars act as metabolic brakes controlling growth initiation in <i>Akkermansia muciniphila</i>.

Gut microbes·2026
Same author

Revised complete genome sequences of <i>Limosilactobacillus reuteri</i> DSM 20016<sup>T</sup> and ATCC PTA-6475 and confirmation of an intragenic macrosatellite in adhesin gene <i>cmbA</i>.

Microbiology spectrum·2026
Same author

A cross-sectional analysis of the vaginal microenvironment in rheumatoid arthritis.

Microbiology spectrum·2026
Same author

Infant gut microbiomes contribute to metabolic states that impact brain function.

bioRxiv : the preprint server for biology·2026
Same author

Radiation-Induced Angiosarcoma of the Breast With Diffuse GATA-3 Positivity: A Possible Diagnostic Pitfall.

The American Journal of dermatopathology·2026

Related Experiment Video

Updated: Jun 19, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
07:57

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis

Published on: December 8, 2011

33.3K

Vaginal microbial dynamics and pathogen colonization in a humanized microbiota mouse model.

Marlyd E Mejia, Vicki Mercado-Evans, Jacob J Zulk

    Biorxiv : the Preprint Server for Biology
    |February 17, 2023
    PubMed
    Summary

    A new humanized microbiota mouse model (HMb mice) better mimics the human vaginal microbiome. These mice show reduced susceptibility to certain urogenital infections, offering a valuable tool for studying microbial protection against pathogens.

    More Related Videos

    A Murine Model of Group B Streptococcus Vaginal Colonization
    10:19

    A Murine Model of Group B Streptococcus Vaginal Colonization

    Published on: November 16, 2016

    14.5K
    Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
    08:53

    Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

    Published on: May 25, 2022

    4.0K

    Related Experiment Videos

    Last Updated: Jun 19, 2026

    Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
    07:57

    Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis

    Published on: December 8, 2011

    33.3K
    A Murine Model of Group B Streptococcus Vaginal Colonization
    10:19

    A Murine Model of Group B Streptococcus Vaginal Colonization

    Published on: November 16, 2016

    14.5K
    Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria
    08:53

    Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

    Published on: May 25, 2022

    4.0K

    Area of Science:

    • Microbiology and Immunology
    • Host-Microbe Interactions
    • Infectious Diseases

    Background:

    • Vaginal microbiota dysbiosis, often lacking Lactobacillus, increases urogenital infection risk.
    • Mechanisms of Lactobacillus-mediated protection against urogenital pathogens remain unclear due to limited in vivo models.
    • Existing mouse models do not accurately reflect the complexity of the human vaginal microbiota.

    Approach:

    • 16S rRNA amplicon sequencing was used to characterize vaginal microbiota in conventional and humanized microbiota mice (HMb mice).
    • HMb mice were challenged with urogenital pathobionts, including Group B Streptococcus (GBS), Prevotella bivia, and uropathogenic E. coli.
    • In vitro and in vivo assays were performed to assess the anti-pathogen activity of specific bacterial isolates from HMb mice.

    Key Points:

    • HMb mice exhibit a more human-like vaginal microbiota, with distinct community state types (h mCST).
    • HMb mice demonstrated reduced susceptibility to uterine GBS and P. bivia colonization compared to conventional mice.
    • Vaginal Enterobacteriaceae and Lactobacillus in HMb mice correlated with the absence of uterine GBS.
    • HMb-derived E. coli, but not L. murinus, conferred protection against vaginal GBS burden in vivo.

    Conclusions:

    • The HMb mouse model provides a more accurate platform for studying the role of the vaginal microbiota in protection against urogenital pathogens.
    • This model can elucidate mechanisms of microbial protection and facilitate the testing of novel probiotic strategies.
    • Environmental factors significantly influence vaginal microbiome composition, highlighting the need for standardized models.